This Week in PNAS

In a study slated to appear in the early, online edition of the Proceedings of the National Academy of Sciences this week, an Ohio State University-led team assessed the expression of hundreds of microRNAs in ovarian cancer tumors, looking for those with expression profiles that coincided with chemotherapy resistance. Through an array-based analysis of almost 700 microRNAs in tumor samples from 86 women with ovarian cancer, researchers tracked down a 23-miRNA signature for chemoresistance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in PNAS

This Week in PNAS

This Week in PNAS

This Week in PNAS

This Week in PNAS

This Week in PNAS

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.